Chronic hepatitis B
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Chronic hepatitis B patients(no cirrhosis): (1) HBsAg positive for at least 6 months; (2) aged 18-75 years; (3) no interferon treatment; (4) Patients who just received Anti-inflammatory and liver-protecting therapy, ALT >=2 ULN, HBV DNA positive, follow-up time >=2 years; (5) anti-viral patients: voluntary nucleoside antiviral therapy, and follow-up time >=2 years, the time of Anti-inflammatory and liver-protecting treatment =7 points were diagnosed as decompensated for hepatitis B cirrhosis.
Exclusion criteria
Exclusion criteria: (1) patients with chronic hepatitis B complicated with drug-induced liver damage, alcoholic liver disease, autoimmune liver disease and other liver diseases; (2) patients with hepatocellular carcinoma; (3) liver cancer occurred within 1 year after treatment; (4) follow-up time of anti-inflammatory and liver-protecting patients less than 2 years; (5) follow-up time of anti-viral patients less than 2 years, anti-inflammatory and liver-protecting treatment time more than 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hcc; | — |
Countries
China
Contacts
Shenzhen Traditional Chinese Medicine Hospital